Philippe Lucas

Tilray, Inc. (NASDAQ: TLRY) announced its support of two clinical cannabis studies in Australia and Canada. The company will provide CBD and THC oral solutions and capsules for the research. “We are committed to advancing cannabinoid-based science to further understand the potential benefits...